Hong Kong-based lender Hang Seng Bank said on Thursday that it was restructuring its business and streamlining duplicate ...

Expert says ‘recent weaknesses in the Hong Kong dollar against other regional currencies’ could help to sustain growth in ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

By Scott Murdoch (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is aiming to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

Treasury yield settles above 4.5%, Nvidia stock rallies ...

Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

Asian shares are mostly higher as a cautious sense of relief spreads through regional markets after the U.S. and China agreed ...

Major stock markets diverged and the dollar slid Wednesday as euphoria over easing US-China trade tensions petered out.